Apoptosis induction by 1α,25-dihydroxyvitamin D3in prostate cancer

Molecular Cancer Therapeutics

Volumn 1, Issue 9, 2002, Pages 667-677

  Guzey, Meral ^a,b   Kitada, Shinichi ^a   Reed, John C ^a  

^a BURNHAM INSTITUTE   (United States)

^b RIGEB   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

CALCITRIOL; CALCIUM CHANNEL STIMULATING AGENT; CASPASE; CYTOCHROME C; LIGAND; PROTEIN BCL 2;

APOPTOSIS; ARTICLE; CELL CULTURE; CELL FRACTIONATION; DOSE RESPONSE; FLUORESCENCE MICROSCOPY; GENETIC TRANSFECTION; HUMAN; IMMUNOBLOTTING; MALE; METABOLISM; MITOCHONDRION; NICK END LABELING; PATHOLOGY; PROSTATE TUMOR; TIME;

APOPTOSIS; CALCITRIOL; CALCIUM CHANNEL AGONISTS; CASPASES; CYTOCHROME C GROUP; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; IMMUNOBLOTTING; IN SITU NICK-END LABELING; LIGANDS; MALE; MICROSCOPY, FLUORESCENCE; MITOCHONDRIA; PROSTATIC NEOPLASMS; PROTO-ONCOGENE PROTEINS C-BCL-2; SUBCELLULAR FRACTIONS; TIME FACTORS; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0036634939     PISSN: 15357163     EISSN: 15388514     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. Gross, C., Peehl, D. M., and Feldman, D. Vitamin D and prostate cancer. In: D. Feldman, F. H. Glorieux, and W. P. Pike (eds.), Vitamin D, pp. 1125-1200. San Diego: Academic Press, 1997.
2. DeLuca, H. F. The vitamin D story: a collaborative effort of basic science and clinical medicine. FASEB J., 2: 224-236, 1988. (Pubitemid 18067863)
3. Darwish, H. M., and DeLuca, H. F. Recent advances in the molecular biology of vitamin D action. Prog. Nucleic Acid Res. Mol. Biol., 53: 321-344, 1996.
4. Glass, C. K. Differential recognition of target genes by nuclear receptor monomers, dimers, and heterodimers. Endocr. Rev., 15: 391-407, 1994. (Pubitemid 24180795)
5. 1. Endocrinology, 138: 1431-1437, 1997.
6. Blutt, S. E., McDonnell, T. J., Polek, T. C., and Weigel, N. L. Calcitriol-induced apoptosis in LNCaP cells is blocked by overexpression of Bcl-2. Endocrinology, 141: 10-17, 2000. (Pubitemid 32260340)
7. Reed, J. C. Apoptosis. In: J. N. Abelson and M. I. Simon (eds.), Methods in Enzymology, Vol. 322, pp. 569. San Diego: Academic Press, 2000.
8. Deveraux, Q. L., Schendel, S. L., and Reed, J. C. Antiapoptotic proteins: the Bcl-2 and inhibitor of apoptosis protein families. In: J. Narula, V. M. Dixit, and L. W. Miller (eds.), Apoptosis in Cardiovascular Disease, Vol. 19, pp. 57-74. Philadelphia: W. B. Saunders Co., 2001. (Pubitemid 32433916)
9. Deveraux, Q. L., and Reed, J. C. IAP family proteins: suppressors of apoptosis. Genes Dev., 13: 239-252, 1999. (Pubitemid 29095796)
10. Holcik, M., and Korneluk, R. G. XIAP, the guardian angel. Nat. Rev. Mol. Cell. Biol., 2: 550-556, 2001. (Pubitemid 33673406)
11. Deveraux, Q. L., Takahashi, R., Salvesen, G. S., and Reed, J. C. X-linked IAP is a direct inhibitor of cell death proteases. Nature (Lond.), 388: 300-304, 1997. (Pubitemid 27317977)
12. Grossman, D., Kim, P. J., Schechner, J. S., and Altieri, D. C. Inhibition of melanoma tumor growth in vivo by survivin targeting. Proc. Natl. Acad. Sci. USA, 98: 635-640, 2001. (Pubitemid 32105095)
13. Guzey, M., and DeLuca, H. F. A group of deltanoids (vitamin D analogs) regulate cell growth and proliferation in small cell carcinoma. Res. Commun. Mol. Pathol. Pharmacol., 98: 3-18, 1997. (Pubitemid 28007618)
14. Furr, H. C., Barua, A. B., and Olson, J. A. Analytical methods. In: Michael B. Sporn, Anita B. Roberts, and D. S. Goodman (eds.), The Retinoids, Ed. 2, pp. 179-209. New York: Raven Press, 1994.
15. Hedlund, T. E., Duke, R. C., and Miller, G. J. Three-dimensional spheroid cultures of human prostate cancer cell lines. Prostate, 41: 154-165, 1999. (Pubitemid 29508609)
16. Spector, D. L., Goldman, R. D., and Leinwand, L. A. Analyzing RNA synthesis: nonisotopic labeling. In: Cells: A laboratory Manual, Vol. 3, pp. 110-110.10. New York: Cold Spring Harbor Laboratory Press, 1998.
17. Haraguchi, M., Torii, S., Matsuzawa, S., Xie, Z., Kitada, S., Yoshida, H., Mak, T. W., and Reed, J. C. Apoptotic protease activating factor (Apaf-1)-independent cell death suppression by Bcl-2. J. Exp. Med., 191: 1709-1720, 2000. (Pubitemid 30332454)
18. Wang, H-G., Miyashita, T., Takayama, S., Sato, T., Torigoe, T., Krajewski, S., Tanaka, S., Hovey, L., III, Troppmai, J., Rapp, U. R., and Reed, J. C. Apoptosis regulation by interaction of Bcl-2 protein and Raf-1 kinase. Oncogene, 9: 2751-2756, 1994. (Pubitemid 24254056)
19. Weislow, O. S., Kiser, R., Fine, D. L., Bader, J., Shoemaker, R. H., and Boyd, M. R. New soluble-formazan assay for HIV-1 cytopathic effects: application to high-flux screening of synthetic and natural products for AIDS-antiviral activity. J. Natl. Cancer Inst., 81: 577-586, 1989. (Pubitemid 19104488)
20. Darzynkiewicz, Z., Juan, G., Li, X., Gorczyca, W., Murakami, T., and Traganos, F. Cytometry in cell necrobiology: analysis of apoptosis and accidental cell death (necrosis). Cytometry, 27: 1-20, 1997. (Pubitemid 27059777)
21. Kaufmann, S. H., Mesner, P. W., Jr., Samejima, K., Tone, S., and Earnshaw, W. C. Detection of DNA cleavage in apoptotic cells. In: J. C. Reed (ed.), Methods in Enzymology, Vol. 322, pp. 3-15. San Diego: Academic Press, 2000. (Pubitemid 30482039)
22. Harlow, E., and Lane, D. Immunoblotting. Antibodies, pp. 474-506. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory, Inc., 1988.
23. Krajewski, S., Krajewska, M., Shabaik, A., Miyashita, T., Wang, H-G., and Reed, J. C. Immunohistochemical determination of in vivo distribution of bax, a dominant inhibitor of Bcl-2. Am. J. Pathol., 145: 1323-1333, 1994.
24. Krajewski, S., Bodrug, S., Gascoyne, R., Berean, K., Krajewska, M., and Reed, J. C. Immunohistochemical analysis of Mcl-1 and Bcl-2 proteins in normal and neoplastic lymph nodes. Am. J. Pathol., 145: 515-525, 1994. (Pubitemid 24285958)
25. Krajewski, S., Bodrug, S., Krajewska, M., Shabaik, A., Gascoyne, R., Berean, K., and Reed, J. C. Immunohistochemical analysis of Mcl-1 protein in human tissues: differential regulation of Mcl-1 and Bcl-2 protein production suggests a unique role for Mcl-1 in control of programmed cell death in vivo. Am. J. Pathol., 146: 1309-1319, 1995.
26. Takayama, S., Krajewski, S., Krajewska, M., Kitada, S., Zapata, J. M., Kochel, K., Knee, D., Scudiero, D., Tudor, G., Miller, G. J., Miyashita, T., Yamada, M., and Reed, J. C. Expression and location of Hsp70/Hsc-binding anti-apoptotic protein BAG-1 and its variants in normal tissues and tumor cell lines. Cancer Res., 58: 3116-3131, 1998. (Pubitemid 28335096)
27. Zhang, H., Huang, Q., Ke, N., Matsuyama, S., Hammock, B., Godzik, A., and Reed, J. C. Drosophila pro-apoptotic bcl-2/bax homologue reveals evolutionary conservation of cell death mechanisms. J. Biol. Chem., 275: 27303-27306, 2000.
28. Yu, L. H., Kawai-Yamada, M., Naito, M., Watanabe, K., Reed, J. C., and Uchimiya, H. Induction of mammalian cell death by a plant Bax inhibitor. FEBS Lett., 512: 308-312, 2002. (Pubitemid 34164500)
29. Stenner-Liewen, F., Liewen, H., Zapata, J. M., Pawlowski, K., Godzik, A., and Reed, J. C. CADD, a chlamydia death domain-containing protein that induces apoptosis. J. Biol. Chem., 277: 9633-9636, 2002. (Pubitemid 34968059)
30. Reed, J. C., Stein, C., Subasinghe, C., Haldar, S., Croce, C. M., Yum, S., and Cohen, J. Antisense-mediated inhibition of BCL2 proto-oncogene expression and leukemic cell growth and survival: comparisons of phosphodiester and phosphorothioate oligodeoxynucleotides. Cancer Res., 50: 6565-6570, 1990. (Pubitemid 20348780)
31. Zar, J. H. Two-samples hypotheses. In: J. H. Zar (ed.), Biostatistical Analysis, Ed. 2, pp. 122-150. Englewood Cliffs, NJ: Prentice-Hall, Inc., 1984.
32. Whitacre, C. M., and Berger, N. A. Factors affecting topotecan-induced programmed cell death: adhesion protects cells from apoptosis and impairs cleavage of poly(ADP-ribose) polymerase. Cancer Res., 57: 2157-2163, 1997. (Pubitemid 27247032)
33. Kluck, R. M., Bossy-Wetzel, E., Green, D. R., and Newmeyer, D. D. The release of cytochrome c from mitochondria: a primary site for Bcl-2 regulation of apoptosis. Science (Wash. DC), 275: 1132-1136, 1997. (Pubitemid 27097313)
34. Wagenknecht, B., Schulz, J. B., Gulbins, E., and Weller, M. Crm-A, bcl-2, and NDGA inhibit CD95L-induced apoptosis of malignant glioma cells at the level of caspase-8 processing. Cell Death Differ., 5: 894-900, 1998. (Pubitemid 28484400)
35. Joza, N., Susin, S. A., Daugas, E., Stanford, W. L., Cho, S. K., Li, C. Y., Sasaki, T., Elia, A. J., Cheng, H-Y. A., Ravagnan, L., Ferri, K. F., Zamzami, N., Wakeham, A., Hakem, R., Yoshida, H., Kong, Y-Y., Mak, T. W., Zúñiga-Pflücker, J. C., Kroemer, G., and Penninger, J. M. Essential role of the mitochondrial apoptosis-inducing factor in programmed cell death. Nature (Lond.), 410: 549-554, 2001. (Pubitemid 32267191)
36. Knee, D. A., Froesch, B. A., Nuber, U., Takayama, S., and Reed, J. C. Structure-function analysis of Bag1 proteins: effects on androgen receptor transcriptional activity. J. Biol. Chem., 276: 12718-12724, 2001.
37. Roy, N., Deveraux, Q. L., Takashashi, R., Salvesen, G. S., and Reed, J. C. The c-IAP-1 and c-IAP-2 proteins are direct inhibitors of specific caspases. EMBO J., 16: 6914-6925, 1997. (Pubitemid 27520792)
38. Tamm, I., Kornblau, S. M., Segall, H., Krajewski, S., Welsh, K., Kitada, S., Scudiero, D. A., Tudor, G., Qui, Y. H., Monks, A., Andreeff, M., and Reed, J. C. Expression and prognostic significance of IAP-family genes in human cancers and myeloid leukemias. Clin. Cancer Res., 6: 1796-1803, 2000. (Pubitemid 30305074)
39. Holcik, M., Lefebvre, C., Yeh, C., Chow, T., and Korneluk, R. G. A new internal-ribosome-entry-site motif potentiates XIAP-mediated cytoprotection. Nat. Cell Biol., 1: 190-192, 1999. (Pubitemid 129656025)
40. Yang, Y., Fang, S., Jensen, J. P., Weissman, A. M., and Ashwell, J. D. Ubiquitin protein ligase activity of IAPs and their degradation in proteasomes in response to apoptotic stimuli. Science (Wash. DC), 288: 874-877, 2000. (Pubitemid 30257739)
41. Kudoh, M., Knee, D. A., Takayama, S., and Reed, J. C. Bag1 proteins regulate growth and survival of ZR-75-1 human breast cancer cells. Cancer Res., 62: 1904-1909, 2002. (Pubitemid 34408520)
42. Guzey, M., Takayama, S., and Reed, J. C. BAG1L enhances transactivation function of the vitamin D receptor. J. Biol. Chem., 275: 40749-40756, 2000. (Pubitemid 32054893)
43. Guzey, M., Sattler, C., and DeLuca, H. F. Combinational effects of vitamin D3 and retinoic acid (all trans and 0 cis) on proliferation, differentiation, and programmed cell death in two small cell lung carcinoma cell lines. Biochem. Biophys. Res. Commun., 249: 735-744, 1998. (Pubitemid 28441909)
44. Freedman, L. P., and Lemon, B. D. Structural and functional determinants of DNA binding and dimerization by the vitamin D receptor. In: D. Feldman, F. H. Glorieux, and W. P. Pike (eds.), Vitamin D, pp. 127-148. San Diego: Academic Press, 1997.
45. Morosetti, R., and Koeffler, H. P. Vitamin D compounds and analogs: effects on normal and abnormal hematopoiesis. In: D. Feldman (ed.), Vitamin D, pp. 1155-1166. San Diego: Academic Press, 1997.
46. Colston, K. Vitamin D and breast cancer: therapeutic potential of new vitamin D analogs. In: D. Feldman, F. H. Glorieux, and J. W. Pike (eds.), Vitamin D, pp. 1107-1123. San Diego: Academic Press, 1997.
47. 3 and its metabolites/analogs. In: D. Feldman, F. H. Glorieux, and W. P. Pike (eds.), Vitamin D, pp. 1141-1154. San Diego: Academic Press, 1997.